Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial
Author(s):
Valayer, S.; Alexandre, M.; Prague, M.; Beavogui, A.H.; Doumbia, S.; Kieh, M.,; Greenwood, B.; Leigh, B.; Poupelin, M.; Schwimmer, C.; Sow, S.O.; Berry, I.M.; Kuhn, J.H.; Fusco, D.; Cauwelaert, N.D.; Watson-Jones, D.; Thiébaut, R.; Lévy, Y..; Yazdanpanah, Y.; Richert, L.; Lhomme, E.; PREVAC study team
